TBPH — 5 insiders, all selling

Form 4 lag: insiders have 2 business days to file after a trade (weekends and holidays extend this), and this site re-ingests once daily — a transaction can appear here roughly three business days after it happened.
13F lag: quarterly 13F-HR holdings cover the prior quarter-end and are due 45 days after it — every institutional position shown here is at least 45 days old by construction, often more.
CUSIP→ticker gaps: 13F positions are reported by CUSIP; some holdings cannot be matched to a current ticker (delistings, corporate actions, thin metadata) and appear without one or are omitted from ticker-level views.
EDGAR timing variability: institutions file at different hours and days within their windows; amended filings (4/A, 13F-HR/A) can restate earlier periods, so historical aggregates may change between batches.

Theravance Biopharma, Inc. · Materials · ISO week 2026-W34 (2026-08-20 → 2026-08-20)

ELEVATED − all sells routine-only window · clu-82788cf00b76 · detected 2026-08-28

5Distinct insiders

5Transactions

−$814kTotal reported value

5Source filings

Members

Insider	Role	Txns	Reported value
Winningham Rick E	CHIEF EXECUTIVE OFFICER	1	$340k
Sawaf Aziz	SVP & CHIEF FINANCIAL OFFICER	1	$137k
Grimaud Brett A.	SVP, GEN COUNSEL AND SECRETARY	1	$135k
Miller Aine	SVP, DEV & HEAD OF IRE OFFICE	1	$106k
Farnum Rhonda	SVP, COMM & MEDICAL AFFAIRS	1	$96k

− Winningham Rick E CHIEF EXECUTIVE OFFICER F routine 20,034 sh @ $16.95 = $340k 0001302443-26-000012
− Sawaf Aziz SVP & CHIEF FINANCIAL OFFICER F routine 8,112 sh @ $16.95 = $137k 0001961289-26-000008
− Grimaud Brett A. SVP, GEN COUNSEL AND SECRETARY F routine 7,952 sh @ $16.95 = $135k 0001966698-26-000008
− Miller Aine SVP, DEV & HEAD OF IRE OFFICE F routine 6,258 sh @ $16.95 = $106k 0002012524-26-000008
− Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS F routine 5,667 sh @ $16.95 = $96k 0001898490-26-000012